Eye Infections Treatment Market: By Type of Infection (Conjunctivitis, Blepharitis, Keratitis, Vitritis, Dry Eye, Chorioretinitis and Neuroretinitis) By Medication (Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals, Aminoglycoside Antibiotics, Others), By Dosage Form (Gels and Cream, Eye drops, Tablets and Capsules), By Distribution Channel (Ophthalmology Clinics, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Eye Infections Treatment Market size was valued at USD 7.2 billion in 2022 and is poised to grow at a CAGR of 3.6% from 2023-29. The global market provides a detailed overview and that can be segmented by type of infection, by medication, by Dosage form, and by distribution channel. By type of infection, the Eye Infections Treatment market growth has been segmented into Conjunctivitis, Blepharitis, Keratitis, Vitritis, Dry Eye, Chorioretinitis and Neuroretinitis. The Conjunctivitis segment is likely to be the largest and fastest-growing segment in terms of type of infection. The rise of this segment is mainly due to a rise in the prevalence of such infections. The segment is expected to witness growth in the forecast period due to the growing number of product launches to cure allergic conjunctivitis. It usually happens in people having seasonal allergies. Based on Medication, the Eye Infections Treatment market is segmented into Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals, Aminoglycoside Antibiotics, and Others. Among these, the Tetracycline Antibiotics medication segment is expected to have a significantly growing market during the forecast period 2022-2028. Based on the Dosage form, the Eye Infections Treatment market is segmented into Gels and Cream, Eye drops, Tablets and Capsules. The Eye drops segment is expected to have a significant share in 2021. Based on the distribution channel, the Eye Infections Treatment market is segmented into Ophthalmology Clinics, Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The hospital pharmacies segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the surge in patient appointments to hospitals for regular eye check-ups and others issues. Besides, the online pharmacies segment is expected to arise as the fastest-growing segment in the eye infection treatment market share

Eye Infections Treatment Market Key Developments:

  • Eyevance Pharmaceuticals announced its partnership with Hikma Pharmaceuticals PLC for the promotion of ZERVIATE, which is used to treat ocular itching concerned with allergic conjunctivitis.

Eye Infections Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.6%

Largest Market

North America

Fastest Growing Market

Europe
Eye Infections Treatment Market Dynamics

Technological Advancements in Treatment and Diagnosis for Eye Infections is anticipated to propel the market growth over the forecast years. Moreover, the growing incidence of multiple vision conditions worldwide is burgeoning the market growth over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Eye Infections Treatment Market Segmentation

By Type of Infection
  • Conjunctivitis
  • Blepharitis
  • Keratitis
  • Vitritis
  • Dry eye
  • Chorioretinitis
  • Neuroretinitis
By Medication
  • Corticosteroids
  • Quinolone Antibiotics
  • Macrolide Antibiotics
  • Tetracycline Antibiotics
  • Polyene Antifungals
  • Aminoglycoside Antibiotics
  • Others
By Dosage Form
  • Gels and Cream
  • Eye drops
  • Tablets and Capsules

Frequently Asked Questions

Growing advanced drug delivery methods for conjunctivitis

In January 2022, NovaBay Pharmaceuticals launched new eye drops to treat dry eye symptoms.

High severe effects of drugs and expiry of the patent

1. Executive Summary
2. Global Eye Infections Treatment Market Introduction 
2.1.Global Eye Infections Treatment Market  - Taxonomy
2.2.Global Eye Infections Treatment Market  - Definitions
2.2.1.Type of Infection
2.2.2.Medication
2.2.3.Dosage Form
2.2.4.Region
3. Global Eye Infections Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Eye Infections Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Eye Infections Treatment Market  By Type of Infection, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Conjunctivitis
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Blepharitis
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Keratitis
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Vitritis
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Dry eye
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Chorioretinitis
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Neuroretinitis
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6. Global Eye Infections Treatment Market  By Medication, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Corticosteroids
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Quinolone Antibiotics
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Macrolide Antibiotics
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Tetracycline Antibiotics
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Polyene Antifungals
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Aminoglycoside Antibiotics
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7. Global Eye Infections Treatment Market  By Dosage Form, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Gels and Cream
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Eye drops
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Tablets and Capsules
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Eye Infections Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Type of Infection Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Conjunctivitis
9.1.2.Blepharitis
9.1.3.Keratitis
9.1.4.Vitritis
9.1.5.Dry eye
9.1.6.Chorioretinitis
9.1.7.Neuroretinitis
9.2.  Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Corticosteroids
9.2.2.Quinolone Antibiotics
9.2.3.Macrolide Antibiotics
9.2.4.Tetracycline Antibiotics
9.2.5.Polyene Antifungals
9.2.6.Aminoglycoside Antibiotics
9.2.7.Others
9.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Gels and Cream
9.3.2.Eye drops
9.3.3.Tablets and Capsules
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Type of Infection Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Conjunctivitis
10.1.2.Blepharitis
10.1.3.Keratitis
10.1.4.Vitritis
10.1.5.Dry eye
10.1.6.Chorioretinitis
10.1.7.Neuroretinitis
10.2.  Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Corticosteroids
10.2.2.Quinolone Antibiotics
10.2.3.Macrolide Antibiotics
10.2.4.Tetracycline Antibiotics
10.2.5.Polyene Antifungals
10.2.6.Aminoglycoside Antibiotics
10.2.7.Others
10.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Gels and Cream
10.3.2.Eye drops
10.3.3.Tablets and Capsules
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11. Asia Pacific (APAC) Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Type of Infection Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Conjunctivitis
11.1.2.Blepharitis
11.1.3.Keratitis
11.1.4.Vitritis
11.1.5.Dry eye
11.1.6.Chorioretinitis
11.1.7.Neuroretinitis
11.2.  Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Corticosteroids
11.2.2.Quinolone Antibiotics
11.2.3.Macrolide Antibiotics
11.2.4.Tetracycline Antibiotics
11.2.5.Polyene Antifungals
11.2.6.Aminoglycoside Antibiotics
11.2.7.Others
11.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Gels and Cream
11.3.2.Eye drops
11.3.3.Tablets and Capsules
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type of Infection Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Conjunctivitis
12.1.2.Blepharitis
12.1.3.Keratitis
12.1.4.Vitritis
12.1.5.Dry eye
12.1.6.Chorioretinitis
12.1.7.Neuroretinitis
12.2.  Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Corticosteroids
12.2.2.Quinolone Antibiotics
12.2.3.Macrolide Antibiotics
12.2.4.Tetracycline Antibiotics
12.2.5.Polyene Antifungals
12.2.6.Aminoglycoside Antibiotics
12.2.7.Others
12.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Gels and Cream
12.3.2.Eye drops
12.3.3.Tablets and Capsules
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Eye Infections Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Type of Infection Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Conjunctivitis
13.1.2.Blepharitis
13.1.3.Keratitis
13.1.4.Vitritis
13.1.5.Dry eye
13.1.6.Chorioretinitis
13.1.7.Neuroretinitis
13.2.  Medication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Corticosteroids
13.2.2.Quinolone Antibiotics
13.2.3.Macrolide Antibiotics
13.2.4.Tetracycline Antibiotics
13.2.5.Polyene Antifungals
13.2.6.Aminoglycoside Antibiotics
13.2.7.Others
13.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Gels and Cream
13.3.2.Eye drops
13.3.3.Tablets and Capsules
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Boehringer Ingelheim GmbH (Germany)
14.2.2.Allergan Inc. (Ireland)
14.2.3.Sanofi-Aventis (France)
14.2.4.Novartis AG (Switzerland)
14.2.5.Bausch & Lomb Inc. (USA)
14.2.6.CIBA Vision Ophthalmics (USA)
14.2.7.Pfizer Inc. (USA)
14.2.8.Merck & Co., Inc. (USA)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Boehringer Ingelheim GmbH (Germany)
  • Allergan Inc. (Ireland)
  • Sanofi-Aventis (France)
  • Novartis AG (Switzerland)
  • Bausch & Lomb Inc. (USA)
  • CIBA Vision Ophthalmics (USA)
  • Pfizer Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Santen Pharmaceuticals Co. Ltd.(Japan)

Adjacent Markets